Skip to main content
. 2024 Jul 23;39(9):1268–1277. doi: 10.1093/jbmr/zjae116

Figure 2.

Figure 2

Patient disposition. The flowchart shows the number of patients included in each cohort from the FRAME and FRAME Extension trials after primary PSW and sensitivity analyses using PSW-MI and PSM. Abbreviations: DMAb = denosumab; MI = multiple imputation; PSM = propensity score matching; PSW = propensity score weighting; Romo = romosozumab.